Glycemic control
Zinc status tracks glycaemic control and repletion helps the deficient — which is not the same thing as a treatment for diabetes.
Not yet investigated
Zinc status tracks glycaemic control and repletion helps the deficient — which is not the same thing as a treatment for diabetes.
This star is on the map because the show intends to take the question apart properly — the trials, how it is actually tested, whether the thing sold is the thing studied. That work is not done yet, and nothing here should be read as a conclusion. When the investigation is published it will appear on this page.
What we are reading
Gathered for the investigation and not yet written up. Each note says what the paper does and does not show.
32 placebo-controlled trials, 1700 people, 14 countries, in the AJCN. Fasting glucose -14.15 mg/dl, 2-hour postprandial -36.85, HbA1c -0.55%, HOMA-IR -0.73, and hs-CRP -1.31 mg/l. Better quality than the chromium literature and the subgroup analysis is the useful part: the effect on fasting glucose depended on diabetic status AND on the FORM of zinc, with inorganic salts outperforming. 'Zinc' on a label is not one intervention.
Connected on the map
Also in Glycemic control
The letter
The full citation list for each investigation, the studies that didn't make the episode, and any corrections — sent the morning it publishes.
No sponsors · No supplement affiliates · Unsubscribe any time
